Patents by Inventor Yoshio Ohba
Yoshio Ohba has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 9333249Abstract: The present invention provides a novel transfer vector and a recombinant baculovirus; methods for the production thereof; pharmaceuticals containing the recombinant baculovirus as an active ingredient, which are useful as preventive or therapeutic drugs for infectious diseases such as malaria and influenza; and methods for preventing and treating infectious diseases such as malaria and influenza. More specifically, the invention provides a recombinant transfer vector capable of expressing a foreign gene fused to a virus gene under the control of a dual promoter; a recombinant baculovirus; methods for the production thereof; pharmaceuticals containing the recombinant baculovirus as an active ingredient; and methods for preventing and treating infectious diseases such as malaria and influenza comprising administrating the recombinant baculovirus to patients.Type: GrantFiled: August 15, 2008Date of Patent: May 10, 2016Assignees: EDUCATIONAL FOUNDATION JICHI MEDICAL UNIVERSITY, OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Shigeto Yoshida, Masanori Kawasaki, Makoto Matsumoto, Yoshio Ohba, Masahiro Saito, Yoshihiro Goto, Katsuya Inagaki, Masami Mizukoshi, Norimitsu Hariguchi, Kuniko Hirota
-
Patent number: 9327018Abstract: The present invention provides a novel transfer vector and a recombinant baculovirus; methods for the production thereof; pharmaceuticals containing the recombinant baculovirus as an active ingredient, which are useful as preventive or therapeutic drugs for infectious diseases such as malaria and influenza; and methods for preventing and treating infectious diseases such as malaria and influenza. More specifically, the invention provides a recombinant transfer vector capable of expressing a foreign gene fused to a virus gene under the control of a dual promoter; a recombinant baculovirus; methods for the production thereof; pharmaceuticals containing the recombinant baculovirus as an active ingredient; and methods for preventing and treating infectious diseases such as malaria and influenza comprising administrating the recombinant baculovirus to patients.Type: GrantFiled: September 14, 2012Date of Patent: May 3, 2016Assignees: EDUCATIONAL FOUNDATION JICHI MEDICAL UNIVERSITY, OTSUKA PHARMACEUTICAL CO., LTD.Inventors: Shigeto Yoshida, Masanori Kawasaki, Makoto Matsumoto, Yoshio Ohba, Masahiro Saito, Yoshihiro Goto, Katsuya Inagaki, Masami Mizukoshi, Norimitsu Hariguchi, Kuniko Hirota
-
Patent number: 9023365Abstract: A recombinant transfer vector capable of expressing a foreign gene fused to a viral gene under the control of dual promoters and a recombinant baculovirus, and methods for production thereof, as well as pharmaceuticals comprising the recombinant baculovirus as an active ingredient.Type: GrantFiled: February 8, 2007Date of Patent: May 5, 2015Assignees: Educational Foundation Jichi Medical University, Otsuka Pharmaceutical Co., Ltd.Inventors: Shigeto Yoshida, Yoshio Ohba, Norimitsu Hariguchi, Masami Mizukoshi, Masanori Kawasaki, Makoto Matsumoto, Yoshihiro Goto
-
Publication number: 20130022637Abstract: The present invention provides a novel transfer vector and a recombinant baculovirus; methods for the production thereof; pharmaceuticals containing the recombinant baculovirus as an active ingredient, which are useful as preventive or therapeutic drugs for infectious diseases such as malaria and influenza; and methods for preventing and treating infectious diseases such as malaria and influenza. More specifically, the invention provides a recombinant transfer vector capable of expressing a foreign gene fused to a virus gene under the control of a dual promoter; a recombinant baculovirus; methods for the production thereof; pharmaceuticals containing the recombinant baculovirus as an active ingredient; and methods for preventing and treating infectious diseases such as malaria and influenza comprising administrating the recombinant baculovirus to patients.Type: ApplicationFiled: September 14, 2012Publication date: January 24, 2013Applicants: OTSUKA PHARMACEUTICAL CO., LTD., EDUCATIONAL FOUNDATION JICHI MEDICAL UNIVERSITYInventors: Shigeto YOSHIDA, Masanori KAWASAKI, Makoto MATSUMOTO, Yoshio OHBA, Masahiro SAITO, Yoshihiro GOTO, Katsuya INAGAKI, Masami MIZUKOSHI, Norimitsu HARIGUCHI, Kuniko HIROTA
-
Publication number: 20100233202Abstract: A recombinant transfer vector capable of expressing a foreign gene fused to a viral gene under the control of dual promoters and a recombinant baculovirus, and methods for production thereof, as well as pharmaceuticals comprising the recombinant baculovirus as an active ingredient.Type: ApplicationFiled: February 8, 2007Publication date: September 16, 2010Inventors: Shigeto Yoshida, Yoshio Ohba, Norimitsu Hariguchi, Masami Mizukoshi, Masanori Kawasaki, Makoto Matsumoto, Yoshihiro Goto
-
Publication number: 20090324702Abstract: The present invention provides a novel transfer vector and a recombinant baculovirus; methods for the production thereof; pharmaceuticals containing the recombinant baculovirus as an active ingredient, which are useful as preventive or therapeutic drugs for infectious diseases such as malaria and influenza; and methods for preventing and treating infectious diseases such as malaria and influenza. More specifically, the invention provides a recombinant transfer vector capable of expressing a foreign gene fused to a virus gene under the control of a dual promoter; a recombinant baculovirus; methods for the production thereof; pharmaceuticals containing the recombinant baculovirus as an active ingredient; and methods for preventing and treating infectious diseases such as malaria and influenza comprising administrating the recombinant baculovirus to patients.Type: ApplicationFiled: August 15, 2008Publication date: December 31, 2009Inventors: Shigeto Yoshida, Masanori Kawasaki, Makoto Matsumoto, Yoshio Ohba, Masahiro Saito, Yoshihiro Goto, Katsuya Inagaki, Masami Mizukoshi, Norimitsu Hariguchi, Kuniko Hirota
-
Patent number: 6866726Abstract: A non-austemper-treated spheroidal graphite cast iron obtainable without being subjected to an austemper treatment. The non-austemper-treated spheroidal graphite cast iron has a tensile strength of 650-850 MPa and an elongation of 7.0-14.5%. In the non-austemper-treated spheroidal graphite cast iron, V-notch material has a fatigue limit of 290 MPa or more. The non-austemper-treated spheroidal graphite cast iron has well-balanced mechanical properties both in tensile strength and elongation and improved tensile strength and elongation than conventional one.Type: GrantFiled: June 7, 2000Date of Patent: March 15, 2005Assignee: Asahi Tec CorporationInventors: Katsumi Suzuki, Noriyuki Nakajima, Yoshio Ohba, Takahiro Ono